I appreciate your personalized customer service and prompt follow up. All I can say is this, if you are this straight forward and direct when something goes wrong, then you treat your customers with respect. And if you do that on a regular basis, you deserve to have great things happen to you in the future.
I will be in touch.
Thanks.
FDA approves Meda allergy combo Dymista - Pharma Times
FDA approves Meda allergy combo DymistaPharma TimesThe approval from the US Food and Drug Administration for Dymista (azelastine and fluticasone) is based on 'several studies involving more than 4000 patients', including one long-term safety study with more than 600 participants.
New Combo Allergy Drug Approved by FDA - Medscape
New Combo Allergy Drug Approved by FDAMedscapeDymista (Meda Pharmaceuticals) nasal spray combines fluticasone propionate (Flonase, GlaxoSmithKline) and azelastine hydrochloride (Astepro, Astelin, Meda Pharmaceuticals).
FDA approves new treatment for seasonal allergic rhinitis - Clinical Advisor
FDA approves new treatment for seasonal allergic rhinitisClinical AdvisorThe FDA has approved azelastine HCI and fluticasone propionate nasal spray (Dymista, Meda) to treat seasonal allergic rhinitis.
Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year ... - MarketWatch (press release)
Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year .
FDA Sends Letter to Meda Pharmaceuticals Over Astepro Telephone Script - PharmaLive.com (press release)
FDA Sends Letter to Meda Pharmaceuticals Over Astepro Telephone ScriptPharmaLive.